The following are four international scientific clinical trails that Dr. Al-Attia had participated in:

1.    The efficacy and safety of sumatriptan in migraneous patients in the UAE (1993).The arterial velocity waves (complior) pre & post

2.    ACE inhibitor in hypertensive patients (1999).

3.    The effectiveness and safety of an individualized Symbicort Tubohaler maintenance-dosing regimen (Symbicort Asthma Control Plan) versus Symbicort Tubohaler given as standard regular twice-daily therapy (2002).

4.    Currently, working on scientific research projects in, DM (FH Arabs with type 2 DM), and rheumatology (HLA typing in PAPS , SLE in Arabs and B 27 in Emiraties: revisited) & osteoporosis in males: (any role for low androgen?, the influence  of age, BMI and 25 OHD3 on the outcome of DXA in elderly Arab males) & discordance between the T score of the femurs and the site of fracture.